Neal Bhai Reports (NBR) — Cipla Rises On U.S. FDA Nod For Immunodeficiency Drug – Shares of the Mumbai-based drugmaker rose as much as 6.47 percent to Rs 622.75 after U.S. FDA gave its final approval to Efavirenz tablets in strength of 600 mg. Efavirenz Tablets 600 mg is AB-rated generic therapeutic equivalent version of Bristol-Myers Squibb Pharma Company’s Sustiva which is used in treatment of human immunodeficiency virus type 1 infection, Cipla said in an exchange filing.
Bond Yield Drops On Reserve Bank’s OMO Plan
Bond Yield Drops On Reserve Bank’s OMO Plan – Yield on India’s 10-year 7.17 percent bond expiring in January 2028 dropped 4 basis points to 7.82 percent after the Reserve Bank of India said it will buyback Rs 10,000 crore of debt via open market operations (OMO) on Thursday, the first …
Ajanta Pharma Share Price – Keep Eye on ₹1059 Below No Buying @all – We See Only Down
Ajanta Pharma Share Price – Keep Eye on ₹1059 Below No Buying @all – We See Only Down
“No Magic, No Miracle, Just Power of Level”
Neal Bhai Reports (NBR) By CFA’s and MFA’s Technical Team
Mobile No. 9582247600 & 9899900589
Stocks Check : Cipla, State Bank Of India And More
Stocks Check: Cipla, State Bank Of India And More 📌 State Bank of India won’t be able to merge more banks with self. 📌 UPL-led consortium is in exclusive talks to acquire Bill Ackman-backed Platform Specialty Products Corp. 📌 Cipla gets final approval for generic drug Sustiva. 📌 The wealth management …
Money Market Heads Up: Rupee Seen Trading In Range Of 68-68.50
Money Market Heads Up: Rupee Seen Trading In Range Of ₹68-68.50 — The RBI said it will buyback Rs 10,000 crore of debt via open market operations on Thursday – the first such OMO operation after May 17. This may help turn the bearish sentiment and see yields declining.
Indian Stock Market Is Driven By Traders From One City
Gold Silver Reports (GSR) – Indian Stock Market Is Driven By Traders From One City – A record number of Indians now have demat accounts but India remains a traders’ stock market driven by one city: Mumbai.
Donald Trump Misguided Trade War
Gold Silver Reports (NBR) – Donald Trump Misguided Trade War — U.S. President Donald Trump may sincerely think he’s battling to win Americans a better deal on trade with China. In fact, he’s making a better deal harder to achieve — and threatening to inflict grave economic damage on the U.S. economy in the process.